Download PDF

Other users also viewed these articles

Dalbavancin as sequential therapy in infective endocarditis: Real-life experience in elder and comorbid patients Eduardo Aparicio-Minguijón; Jorge Boán; Antonio Terrón; Carlos Heredia; Cristina Puente; Asunción Pérez-Jacoiste Asín; M. Ángeles Orellana; Laura Domínguez; José Manuel Caro; M. Jesús López-Gude; Eva María Aguilar-Blanco; Andrea Eixerés-Esteve; Francisco López-Medrano;
Enferm Infecc Microbiol Clin. 2025;43:86-92
Dalbavancin as consolidation antibiotic treatment in infective endocarditis, cardiac implantable electronic devices infection and bacteremia: Clinical experience of 7 years Alejandro Salinas-Botrán; Carmen Olmos-Blanco; David Fernández de Velasco-Pérez; Alicia Guzmán-Carreras; Alejandro Morales-Rosas; Daniel Gómez-Ramírez;
Enferm Infecc Microbiol Clin. 2025;43:71-9
Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT Natividad Benito; Juan Carlos Martínez-Pastor; Jaime Lora-Tamayo; Javier Ariza; José Baeza; Joaquín Belzunegui-Otano; Javier Cobo; María-Dolores del-Toro; Cesar G. Fontecha; Lluís Font-Vizcarra; Juan P. Horcajada; Laura Morata; Oscar Murillo; Joan M. Nolla; Esmeralda Núñez-Cuadros; Carlos Pigrau; María Eugenia Portillo; Dolors Rodríguez-Pardo; Beatriz Sobrino-Díaz; Jesús Saavedra-Lozano;
Enferm Infecc Microbiol Clin. 2024;42:208-14